nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0655	0.2	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Fluocinonide—psoriasis	0.0655	0.2	CiPCiCtD
Amcinonide—Clobetasol propionate—psoriasis	0.051	0.195	CrCtD
Amcinonide—ANXA1—Hydrocortisone—psoriasis	0.0434	0.257	CbGbCtD
Amcinonide—Beclomethasone—psoriasis	0.0409	0.156	CrCtD
Amcinonide—Fluocinonide—psoriasis	0.0409	0.156	CrCtD
Amcinonide—Fluocinolone Acetonide—psoriasis	0.0397	0.152	CrCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Hydrocortisone—psoriasis	0.0376	0.115	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—psoriasis	0.0331	0.101	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—psoriasis	0.0331	0.101	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.032	0.0978	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.031	0.0947	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—psoriasis	0.0293	0.0894	CiPCiCtD
Amcinonide—ANXA1—Dexamethasone—psoriasis	0.027	0.16	CbGbCtD
Amcinonide—NR3C1—Clobetasol propionate—psoriasis	0.0209	0.124	CbGbCtD
Amcinonide—Dexamethasone—psoriasis	0.0186	0.0711	CrCtD
Amcinonide—Betamethasone—psoriasis	0.0186	0.0711	CrCtD
Amcinonide—Triamcinolone—psoriasis	0.0182	0.0695	CrCtD
Amcinonide—Prednisone—psoriasis	0.0173	0.0659	CrCtD
Amcinonide—Prednisolone—psoriasis	0.0169	0.0643	CrCtD
Amcinonide—NR3C1—Beclomethasone—psoriasis	0.0158	0.0937	CbGbCtD
Amcinonide—NR3C1—Fluocinonide—psoriasis	0.0158	0.0937	CbGbCtD
Amcinonide—NR3C1—Fluocinolone Acetonide—psoriasis	0.0158	0.0937	CbGbCtD
Amcinonide—NR3C1—Triamcinolone—psoriasis	0.0063	0.0373	CbGbCtD
Amcinonide—NR3C1—Betamethasone—psoriasis	0.00541	0.032	CbGbCtD
Amcinonide—NR3C1—Prednisolone—psoriasis	0.00533	0.0316	CbGbCtD
Amcinonide—NR3C1—Hydrocortisone—psoriasis	0.00506	0.0299	CbGbCtD
Amcinonide—NR3C1—Prednisone—psoriasis	0.00504	0.0298	CbGbCtD
Amcinonide—NR3C1—Dexamethasone—psoriasis	0.00315	0.0186	CbGbCtD
Amcinonide—Dermatitis infected—Clobetasol propionate—psoriasis	0.00216	0.042	CcSEcCtD
Amcinonide—Pyoderma—Clobetasol propionate—psoriasis	0.00216	0.042	CcSEcCtD
Amcinonide—Ciclesonide—Clobetasol propionate—psoriasis	0.00195	0.0104	CrCrCtD
Amcinonide—Fluticasone furoate—Clobetasol propionate—psoriasis	0.00187	0.01	CrCrCtD
Amcinonide—Flumethasone Pivalate—Clobetasol propionate—psoriasis	0.00168	0.00902	CrCrCtD
Amcinonide—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00163	0.00873	CrCrCtD
Amcinonide—Halobetasol Propionate—Clobetasol propionate—psoriasis	0.00163	0.00873	CrCrCtD
Amcinonide—Difluprednate—Clobetasol propionate—psoriasis	0.00163	0.00873	CrCrCtD
Amcinonide—Ciclesonide—Fluocinonide—psoriasis	0.00156	0.00836	CrCrCtD
Amcinonide—Ciclesonide—Beclomethasone—psoriasis	0.00156	0.00836	CrCrCtD
Amcinonide—Beclomethasone—Clobetasol propionate—psoriasis	0.00153	0.00821	CrCrCtD
Amcinonide—Fluocinonide—Clobetasol propionate—psoriasis	0.00153	0.00821	CrCrCtD
Amcinonide—Prednicarbate—Clobetasol propionate—psoriasis	0.00153	0.00821	CrCrCtD
Amcinonide—Fluticasone furoate—Beclomethasone—psoriasis	0.0015	0.00804	CrCrCtD
Amcinonide—Fluticasone furoate—Fluocinonide—psoriasis	0.0015	0.00804	CrCrCtD
Amcinonide—Fluticasone furoate—Fluocinolone Acetonide—psoriasis	0.00146	0.00781	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.00145	0.00775	CrCrCtD
Amcinonide—Budesonide—Clobetasol propionate—psoriasis	0.00141	0.00755	CrCrCtD
Amcinonide—Fluoxymesterone—Clobetasol propionate—psoriasis	0.00141	0.00755	CrCrCtD
Amcinonide—Flurandrenolide—Fluocinonide—psoriasis	0.00139	0.00748	CrCrCtD
Amcinonide—Desonide—Clobetasol propionate—psoriasis	0.00137	0.00735	CrCrCtD
Amcinonide—Prednisone—Clobetasol propionate—psoriasis	0.00137	0.00735	CrCrCtD
Amcinonide—Diflorasone—Clobetasol propionate—psoriasis	0.00137	0.00735	CrCrCtD
Amcinonide—Fludrocortisone—Clobetasol propionate—psoriasis	0.00137	0.00735	CrCrCtD
Amcinonide—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.00135	0.00727	CrCrCtD
Amcinonide—Flumethasone Pivalate—Fluocinonide—psoriasis	0.00135	0.00723	CrCrCtD
Amcinonide—Flumethasone Pivalate—Beclomethasone—psoriasis	0.00135	0.00723	CrCrCtD
Amcinonide—Pustule—Clobetasol propionate—psoriasis	0.00133	0.0259	CcSEcCtD
Amcinonide—Flumethasone Pivalate—Fluocinolone Acetonide—psoriasis	0.00131	0.00702	CrCrCtD
Amcinonide—Difluprednate—Fluocinonide—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Difluprednate—Beclomethasone—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Fluticasone Propionate—Fluocinonide—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Fluticasone Propionate—Beclomethasone—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Halobetasol Propionate—Fluocinonide—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Halobetasol Propionate—Beclomethasone—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Desoximetasone—Clobetasol propionate—psoriasis	0.0013	0.00699	CrCrCtD
Amcinonide—Triamcinolone—Clobetasol propionate—psoriasis	0.00127	0.00683	CrCrCtD
Amcinonide—Mometasone—Clobetasol propionate—psoriasis	0.00127	0.00683	CrCrCtD
Amcinonide—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00127	0.00683	CrCrCtD
Amcinonide—Loteprednol—Clobetasol propionate—psoriasis	0.00127	0.00683	CrCrCtD
Amcinonide—Fluorometholone—Clobetasol propionate—psoriasis	0.00127	0.00683	CrCrCtD
Amcinonide—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.00127	0.0068	CrCrCtD
Amcinonide—Difluprednate—Fluocinolone Acetonide—psoriasis	0.00127	0.0068	CrCrCtD
Amcinonide—Halobetasol Propionate—Fluocinolone Acetonide—psoriasis	0.00127	0.0068	CrCrCtD
Amcinonide—Rimexolone—Clobetasol propionate—psoriasis	0.00124	0.00667	CrCrCtD
Amcinonide—Betamethasone—Clobetasol propionate—psoriasis	0.00124	0.00667	CrCrCtD
Amcinonide—Dexamethasone—Clobetasol propionate—psoriasis	0.00124	0.00667	CrCrCtD
Amcinonide—Beclomethasone—Fluocinonide—psoriasis	0.00123	0.00658	CrCrCtD
Amcinonide—Prednicarbate—Beclomethasone—psoriasis	0.00123	0.00658	CrCrCtD
Amcinonide—Fluocinonide—Beclomethasone—psoriasis	0.00123	0.00658	CrCrCtD
Amcinonide—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.00119	0.00639	CrCrCtD
Amcinonide—Beclomethasone—Fluocinolone Acetonide—psoriasis	0.00119	0.00639	CrCrCtD
Amcinonide—Prednisolone—Clobetasol propionate—psoriasis	0.00116	0.00625	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Fluocinonide—psoriasis	0.00116	0.00621	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.00116	0.00621	CrCrCtD
Amcinonide—Budesonide—Beclomethasone—psoriasis	0.00113	0.00604	CrCrCtD
Amcinonide—Budesonide—Fluocinonide—psoriasis	0.00113	0.00604	CrCrCtD
Amcinonide—Desonide—Fluocinonide—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Clobetasol propionate—Beclomethasone—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Diflorasone—Fluocinonide—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Flunisolide—Fluocinonide—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Clobetasol propionate—Fluocinonide—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Desonide—Beclomethasone—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Diflorasone—Beclomethasone—psoriasis	0.0011	0.00589	CrCrCtD
Amcinonide—Budesonide—Fluocinolone Acetonide—psoriasis	0.00109	0.00587	CrCrCtD
Amcinonide—Desonide—Fluocinolone Acetonide—psoriasis	0.00107	0.00572	CrCrCtD
Amcinonide—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.00107	0.00572	CrCrCtD
Amcinonide—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00107	0.00572	CrCrCtD
Amcinonide—Flunisolide—Fluocinolone Acetonide—psoriasis	0.00107	0.00572	CrCrCtD
Amcinonide—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00107	0.00572	CrCrCtD
Amcinonide—Desoximetasone—Fluocinonide—psoriasis	0.00104	0.0056	CrCrCtD
Amcinonide—Desoximetasone—Beclomethasone—psoriasis	0.00104	0.0056	CrCrCtD
Amcinonide—Secondary adrenocortical insufficiency—Clobetasol propionate—psoriasis	0.00104	0.0202	CcSEcCtD
Amcinonide—Triamcinolone—Beclomethasone—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Fluprednidene Acetate—Fluocinonide—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Mometasone—Beclomethasone—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Mometasone—Fluocinonide—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Loteprednol—Beclomethasone—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Fluorometholone—Beclomethasone—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Triamcinolone—Fluocinonide—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Fluorometholone—Fluocinonide—psoriasis	0.00102	0.00547	CrCrCtD
Amcinonide—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00101	0.00544	CrCrCtD
Amcinonide—Dexamethasone—Beclomethasone—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Betamethasone—Fluocinonide—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Rimexolone—Beclomethasone—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Betamethasone—Beclomethasone—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Dexamethasone—Fluocinonide—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Rimexolone—Fluocinonide—psoriasis	0.000996	0.00534	CrCrCtD
Amcinonide—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.000991	0.00531	CrCrCtD
Amcinonide—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.000991	0.00531	CrCrCtD
Amcinonide—Mometasone—Fluocinolone Acetonide—psoriasis	0.000991	0.00531	CrCrCtD
Amcinonide—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.000991	0.00531	CrCrCtD
Amcinonide—Rimexolone—Fluocinolone Acetonide—psoriasis	0.000968	0.00519	CrCrCtD
Amcinonide—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000968	0.00519	CrCrCtD
Amcinonide—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000968	0.00519	CrCrCtD
Amcinonide—Skin atrophy—Calcipotriol—psoriasis	0.000955	0.0185	CcSEcCtD
Amcinonide—Secondary adrenocortical insufficiency—Beclomethasone—psoriasis	0.000946	0.0184	CcSEcCtD
Amcinonide—Secondary adrenocortical insufficiency—Fluocinonide—psoriasis	0.000938	0.0182	CcSEcCtD
Amcinonide—Prednisolone—Beclomethasone—psoriasis	0.000932	0.005	CrCrCtD
Amcinonide—Prednisolone—Fluocinolone Acetonide—psoriasis	0.000906	0.00486	CrCrCtD
Amcinonide—Dermatitis perioral—Clobetasol propionate—psoriasis	0.000794	0.0154	CcSEcCtD
Amcinonide—Telangiectasia—Clobetasol propionate—psoriasis	0.000765	0.0149	CcSEcCtD
Amcinonide—Ciclesonide—Hydrocortisone—psoriasis	0.000765	0.0041	CrCrCtD
Amcinonide—Pustule—Fluocinolone Acetonide—psoriasis	0.00075	0.0146	CcSEcCtD
Amcinonide—Dermatitis perioral—Fluocinonide—psoriasis	0.000716	0.0139	CcSEcCtD
Amcinonide—Acneiform eruption—Clobetasol propionate—psoriasis	0.000714	0.0139	CcSEcCtD
Amcinonide—Telangiectasia—Fluocinonide—psoriasis	0.00069	0.0134	CcSEcCtD
Amcinonide—Flurandrenolide—Hydrocortisone—psoriasis	0.000684	0.00367	CrCrCtD
Amcinonide—Fluticasone furoate—Betamethasone—psoriasis	0.000683	0.00366	CrCrCtD
Amcinonide—Fluticasone furoate—Dexamethasone—psoriasis	0.000683	0.00366	CrCrCtD
Amcinonide—Fluticasone furoate—Triamcinolone—psoriasis	0.000667	0.00358	CrCrCtD
Amcinonide—Ciclesonide—Prednisone—psoriasis	0.000659	0.00353	CrCrCtD
Amcinonide—Acneiform eruption—Fluocinonide—psoriasis	0.000644	0.0125	CcSEcCtD
Amcinonide—Ciclesonide—Prednisolone—psoriasis	0.000643	0.00345	CrCrCtD
Amcinonide—Flurandrenolide—Dexamethasone—psoriasis	0.000635	0.00341	CrCrCtD
Amcinonide—Flurandrenolide—Betamethasone—psoriasis	0.000635	0.00341	CrCrCtD
Amcinonide—Cataract subcapsular—Beclomethasone—psoriasis	0.000629	0.0122	CcSEcCtD
Amcinonide—Cataract subcapsular—Fluocinonide—psoriasis	0.000623	0.0121	CcSEcCtD
Amcinonide—Cortisone acetate—Hydrocortisone—psoriasis	0.00062	0.00333	CrCrCtD
Amcinonide—Flumethasone Pivalate—Dexamethasone—psoriasis	0.000614	0.00329	CrCrCtD
Amcinonide—Flumethasone Pivalate—Betamethasone—psoriasis	0.000614	0.00329	CrCrCtD
Amcinonide—Secondary infection—Clobetasol propionate—psoriasis	0.000614	0.0119	CcSEcCtD
Amcinonide—Miliaria—Clobetasol propionate—psoriasis	0.000614	0.0119	CcSEcCtD
Amcinonide—Prednicarbate—Hydrocortisone—psoriasis	0.000602	0.00323	CrCrCtD
Amcinonide—Flumethasone Pivalate—Triamcinolone—psoriasis	0.0006	0.00322	CrCrCtD
Amcinonide—Skin atrophy—Clobetasol propionate—psoriasis	0.000597	0.0116	CcSEcCtD
Amcinonide—Fluticasone Propionate—Betamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Halobetasol Propionate—Dexamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Difluprednate—Dexamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Difluprednate—Betamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Fluticasone Propionate—Dexamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Halobetasol Propionate—Betamethasone—psoriasis	0.000594	0.00319	CrCrCtD
Amcinonide—Halobetasol Propionate—Triamcinolone—psoriasis	0.000581	0.00311	CrCrCtD
Amcinonide—Difluprednate—Triamcinolone—psoriasis	0.000581	0.00311	CrCrCtD
Amcinonide—Fluticasone Propionate—Triamcinolone—psoriasis	0.000581	0.00311	CrCrCtD
Amcinonide—Flurandrenolide—Prednisolone—psoriasis	0.000575	0.00308	CrCrCtD
Amcinonide—Skin striae—Clobetasol propionate—psoriasis	0.000567	0.011	CcSEcCtD
Amcinonide—Prednicarbate—Betamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Beclomethasone—Betamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Beclomethasone—Dexamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Fluocinonide—Dexamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Fluocinonide—Betamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Prednicarbate—Dexamethasone—psoriasis	0.000559	0.003	CrCrCtD
Amcinonide—Miliaria—Fluocinonide—psoriasis	0.000553	0.0107	CcSEcCtD
Amcinonide—Secondary infection—Fluocinonide—psoriasis	0.000553	0.0107	CcSEcCtD
Amcinonide—Atrophy—Clobetasol propionate—psoriasis	0.000553	0.0107	CcSEcCtD
Amcinonide—Fluoxymesterone—Hydrocortisone—psoriasis	0.000553	0.00297	CrCrCtD
Amcinonide—Budesonide—Hydrocortisone—psoriasis	0.000553	0.00297	CrCrCtD
Amcinonide—Beclomethasone—Triamcinolone—psoriasis	0.000546	0.00293	CrCrCtD
Amcinonide—Prednicarbate—Triamcinolone—psoriasis	0.000546	0.00293	CrCrCtD
Amcinonide—Fluocinonide—Triamcinolone—psoriasis	0.000546	0.00293	CrCrCtD
Amcinonide—Skin atrophy—Beclomethasone—psoriasis	0.000544	0.0106	CcSEcCtD
Amcinonide—Skin atrophy—Fluocinonide—psoriasis	0.000539	0.0105	CcSEcCtD
Amcinonide—Prednisone—Hydrocortisone—psoriasis	0.000539	0.00289	CrCrCtD
Amcinonide—Desonide—Hydrocortisone—psoriasis	0.000539	0.00289	CrCrCtD
Amcinonide—Flunisolide—Hydrocortisone—psoriasis	0.000539	0.00289	CrCrCtD
Amcinonide—Fludrocortisone—Hydrocortisone—psoriasis	0.000539	0.00289	CrCrCtD
Amcinonide—Cortisone acetate—Prednisone—psoriasis	0.000534	0.00286	CrCrCtD
Amcinonide—Dermatitis acneiform—Clobetasol propionate—psoriasis	0.000528	0.0102	CcSEcCtD
Amcinonide—Fluocinolone Acetonide—Dexamethasone—psoriasis	0.000528	0.00283	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Betamethasone—psoriasis	0.000528	0.00283	CrCrCtD
Amcinonide—Cortisone acetate—Prednisolone—psoriasis	0.000521	0.0028	CrCrCtD
Amcinonide—Prednicarbate—Prednisone—psoriasis	0.000518	0.00278	CrCrCtD
Amcinonide—Skin striae—Beclomethasone—psoriasis	0.000516	0.01	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Clobetasol propionate—psoriasis	0.000516	0.01	CcSEcCtD
Amcinonide—Fluocinolone Acetonide—Triamcinolone—psoriasis	0.000516	0.00277	CrCrCtD
Amcinonide—Fluoxymesterone—Dexamethasone—psoriasis	0.000514	0.00275	CrCrCtD
Amcinonide—Fluoxymesterone—Betamethasone—psoriasis	0.000514	0.00275	CrCrCtD
Amcinonide—Budesonide—Betamethasone—psoriasis	0.000514	0.00275	CrCrCtD
Amcinonide—Budesonide—Dexamethasone—psoriasis	0.000514	0.00275	CrCrCtD
Amcinonide—Desoximetasone—Hydrocortisone—psoriasis	0.000512	0.00275	CrCrCtD
Amcinonide—Skin striae—Fluocinonide—psoriasis	0.000512	0.00993	CcSEcCtD
Amcinonide—Acneiform eruption—Methoxsalen—psoriasis	0.000508	0.00986	CcSEcCtD
Amcinonide—Prednicarbate—Prednisolone—psoriasis	0.000506	0.00271	CrCrCtD
Amcinonide—Beclomethasone—Prednisolone—psoriasis	0.000506	0.00271	CrCrCtD
Amcinonide—Fluoxymesterone—Triamcinolone—psoriasis	0.000502	0.00269	CrCrCtD
Amcinonide—Budesonide—Triamcinolone—psoriasis	0.000502	0.00269	CrCrCtD
Amcinonide—Leukoderma—Tazarotene—psoriasis	0.0005	0.00971	CcSEcCtD
Amcinonide—Triamcinolone—Hydrocortisone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Mometasone—Hydrocortisone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Fluorometholone—Hydrocortisone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Loteprednol—Hydrocortisone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Prednisone—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Diflorasone—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Diflorasone—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Flunisolide—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Fludrocortisone—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Flunisolide—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Desonide—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Fludrocortisone—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Desonide—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Prednisone—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Clobetasol propionate—Betamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Clobetasol propionate—Dexamethasone—psoriasis	0.0005	0.00268	CrCrCtD
Amcinonide—Atrophy—Fluocinonide—psoriasis	0.000499	0.00969	CcSEcCtD
Amcinonide—Betamethasone—Hydrocortisone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Dexamethasone—Hydrocortisone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Rimexolone—Hydrocortisone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Fludrocortisone—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Diflorasone—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Flunisolide—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Prednisone—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Clobetasol propionate—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Desonide—Triamcinolone—psoriasis	0.000489	0.00262	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Prednisolone—psoriasis	0.000478	0.00256	CrCrCtD
Amcinonide—Budesonide—Prednisone—psoriasis	0.000476	0.00255	CrCrCtD
Amcinonide—Dermatitis acneiform—Fluocinonide—psoriasis	0.000476	0.00924	CcSEcCtD
Amcinonide—Desoximetasone—Betamethasone—psoriasis	0.000476	0.00255	CrCrCtD
Amcinonide—Desoximetasone—Dexamethasone—psoriasis	0.000476	0.00255	CrCrCtD
Amcinonide—Hypertrichosis—Clobetasol propionate—psoriasis	0.000474	0.00921	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Fluocinonide—psoriasis	0.000466	0.00904	CcSEcCtD
Amcinonide—Desoximetasone—Triamcinolone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Budesonide—Prednisolone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Fluoxymesterone—Prednisolone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Loteprednol—Betamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Loteprednol—Dexamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Fluorometholone—Betamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Fluorometholone—Dexamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Triamcinolone—Dexamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Triamcinolone—Betamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Mometasone—Dexamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Mometasone—Betamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Fluprednidene Acetate—Dexamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Fluprednidene Acetate—Betamethasone—psoriasis	0.000465	0.00249	CrCrCtD
Amcinonide—Diflorasone—Prednisone—psoriasis	0.000464	0.00249	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisone—psoriasis	0.000464	0.00249	CrCrCtD
Amcinonide—Desonide—Prednisone—psoriasis	0.000464	0.00249	CrCrCtD
Amcinonide—Fludrocortisone—Prednisone—psoriasis	0.000464	0.00249	CrCrCtD
Amcinonide—Flunisolide—Prednisone—psoriasis	0.000464	0.00249	CrCrCtD
Amcinonide—Folliculitis—Calcipotriol—psoriasis	0.000459	0.00891	CcSEcCtD
Amcinonide—Prednisolone—Hydrocortisone—psoriasis	0.000458	0.00246	CrCrCtD
Amcinonide—Dexamethasone—Betamethasone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Rimexolone—Dexamethasone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Rimexolone—Betamethasone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Betamethasone—Dexamethasone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Loteprednol—Triamcinolone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Fluorometholone—Triamcinolone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Mometasone—Triamcinolone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000454	0.00244	CrCrCtD
Amcinonide—Flunisolide—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Prednisone—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Diflorasone—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Fludrocortisone—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Desonide—Prednisolone—psoriasis	0.000453	0.00243	CrCrCtD
Amcinonide—Dermatitis perioral—Fluocinolone Acetonide—psoriasis	0.000447	0.00868	CcSEcCtD
Amcinonide—Dexamethasone—Triamcinolone—psoriasis	0.000444	0.00238	CrCrCtD
Amcinonide—Rimexolone—Triamcinolone—psoriasis	0.000444	0.00238	CrCrCtD
Amcinonide—Betamethasone—Triamcinolone—psoriasis	0.000444	0.00238	CrCrCtD
Amcinonide—Desoximetasone—Prednisone—psoriasis	0.000441	0.00237	CrCrCtD
Amcinonide—Miliaria—Methoxsalen—psoriasis	0.000437	0.00848	CcSEcCtD
Amcinonide—Hypertrichosis—Beclomethasone—psoriasis	0.000432	0.00838	CcSEcCtD
Amcinonide—Telangiectasia—Fluocinolone Acetonide—psoriasis	0.000431	0.00836	CcSEcCtD
Amcinonide—Fluorometholone—Prednisone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Triamcinolone—Prednisone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Loteprednol—Prednisone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Mometasone—Prednisone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Desoximetasone—Prednisolone—psoriasis	0.000431	0.00231	CrCrCtD
Amcinonide—Hypertrichosis—Fluocinonide—psoriasis	0.000428	0.0083	CcSEcCtD
Amcinonide—Prednisolone—Dexamethasone—psoriasis	0.000425	0.00228	CrCrCtD
Amcinonide—Prednisolone—Betamethasone—psoriasis	0.000425	0.00228	CrCrCtD
Amcinonide—Leukoderma—Clobetasol propionate—psoriasis	0.000424	0.00823	CcSEcCtD
Amcinonide—Rimexolone—Prednisone—psoriasis	0.000421	0.00226	CrCrCtD
Amcinonide—Betamethasone—Prednisone—psoriasis	0.000421	0.00226	CrCrCtD
Amcinonide—Dexamethasone—Prednisone—psoriasis	0.000421	0.00226	CrCrCtD
Amcinonide—Fluorometholone—Prednisolone—psoriasis	0.00042	0.00226	CrCrCtD
Amcinonide—Triamcinolone—Prednisolone—psoriasis	0.00042	0.00226	CrCrCtD
Amcinonide—Mometasone—Prednisolone—psoriasis	0.00042	0.00226	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisolone—psoriasis	0.00042	0.00226	CrCrCtD
Amcinonide—Loteprednol—Prednisolone—psoriasis	0.00042	0.00226	CrCrCtD
Amcinonide—Prednisolone—Triamcinolone—psoriasis	0.000415	0.00223	CrCrCtD
Amcinonide—Rimexolone—Prednisolone—psoriasis	0.000411	0.0022	CrCrCtD
Amcinonide—Dexamethasone—Prednisolone—psoriasis	0.000411	0.0022	CrCrCtD
Amcinonide—Betamethasone—Prednisolone—psoriasis	0.000411	0.0022	CrCrCtD
Amcinonide—Acneiform eruption—Fluocinolone Acetonide—psoriasis	0.000402	0.0078	CcSEcCtD
Amcinonide—Prednisolone—Prednisone—psoriasis	0.000394	0.00211	CrCrCtD
Amcinonide—Cataract subcapsular—Acitretin—psoriasis	0.00039	0.00757	CcSEcCtD
Amcinonide—Cataract subcapsular—Fluocinolone Acetonide—psoriasis	0.000389	0.00755	CcSEcCtD
Amcinonide—Leukoderma—Fluocinonide—psoriasis	0.000383	0.00743	CcSEcCtD
Amcinonide—Dermatitis acneiform—Methoxsalen—psoriasis	0.000376	0.00729	CcSEcCtD
Amcinonide—Stinging—Calcipotriol—psoriasis	0.000356	0.00691	CcSEcCtD
Amcinonide—Miliaria—Fluocinolone Acetonide—psoriasis	0.000345	0.0067	CcSEcCtD
Amcinonide—Secondary infection—Fluocinolone Acetonide—psoriasis	0.000345	0.0067	CcSEcCtD
Amcinonide—Skin atrophy—Acitretin—psoriasis	0.000337	0.00654	CcSEcCtD
Amcinonide—Skin atrophy—Fluocinolone Acetonide—psoriasis	0.000336	0.00652	CcSEcCtD
Amcinonide—Skin striae—Fluocinolone Acetonide—psoriasis	0.000319	0.0062	CcSEcCtD
Amcinonide—Leukoderma—Methoxsalen—psoriasis	0.000302	0.00586	CcSEcCtD
Amcinonide—Dermatitis acneiform—Fluocinolone Acetonide—psoriasis	0.000297	0.00577	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Fluocinolone Acetonide—psoriasis	0.000291	0.00564	CcSEcCtD
Amcinonide—Folliculitis—Clobetasol propionate—psoriasis	0.000287	0.00557	CcSEcCtD
Amcinonide—Secondary adrenocortical insufficiency—Hydrocortisone—psoriasis	0.000277	0.00539	CcSEcCtD
Amcinonide—Hypertrichosis—Acitretin—psoriasis	0.000268	0.0052	CcSEcCtD
Amcinonide—Hypertrichosis—Fluocinolone Acetonide—psoriasis	0.000267	0.00518	CcSEcCtD
Amcinonide—Skin atrophy—Hydroxyurea—psoriasis	0.000265	0.00514	CcSEcCtD
Amcinonide—Stinging—Tazarotene—psoriasis	0.000263	0.0051	CcSEcCtD
Amcinonide—Folliculitis—Fluocinonide—psoriasis	0.000259	0.00502	CcSEcCtD
Amcinonide—Atrophy—Hydroxyurea—psoriasis	0.000245	0.00476	CcSEcCtD
Amcinonide—Leukoderma—Fluocinolone Acetonide—psoriasis	0.000239	0.00463	CcSEcCtD
Amcinonide—Rash pustular—Clobetasol propionate—psoriasis	0.000226	0.00439	CcSEcCtD
Amcinonide—Stinging—Clobetasol propionate—psoriasis	0.000223	0.00432	CcSEcCtD
Amcinonide—Dermatitis perioral—Hydrocortisone—psoriasis	0.000212	0.00411	CcSEcCtD
Amcinonide—Dermatitis contact—Tazarotene—psoriasis	0.00021	0.00408	CcSEcCtD
Amcinonide—Tenderness—Clobetasol propionate—psoriasis	0.000207	0.00401	CcSEcCtD
Amcinonide—Secondary adrenocortical insufficiency—Prednisone—psoriasis	0.000206	0.00401	CcSEcCtD
Amcinonide—Atrophy—Mycophenolic acid—psoriasis	0.000205	0.00399	CcSEcCtD
Amcinonide—Folliculitis—Methoxsalen—psoriasis	0.000204	0.00396	CcSEcCtD
Amcinonide—Telangiectasia—Hydrocortisone—psoriasis	0.000204	0.00396	CcSEcCtD
Amcinonide—Dermatitis perioral—Triamcinolone—psoriasis	0.0002	0.00387	CcSEcCtD
Amcinonide—Acneiform eruption—Hydrocortisone—psoriasis	0.000191	0.0037	CcSEcCtD
Amcinonide—Cataract subcapsular—Prednisolone—psoriasis	0.000189	0.00366	CcSEcCtD
Amcinonide—Cataract subcapsular—Hydrocortisone—psoriasis	0.000184	0.00358	CcSEcCtD
Amcinonide—Dermatitis perioral—Dexamethasone—psoriasis	0.000181	0.00352	CcSEcCtD
Amcinonide—Dermatitis perioral—Betamethasone—psoriasis	0.000181	0.00352	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—HCAR2—psoriasis	0.000181	0.0453	CbGpPWpGaD
Amcinonide—Acneiform eruption—Triamcinolone—psoriasis	0.000179	0.00348	CcSEcCtD
Amcinonide—Dermatitis contact—Clobetasol propionate—psoriasis	0.000178	0.00346	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000177	0.0442	CbGpPWpGaD
Amcinonide—Telangiectasia—Dexamethasone—psoriasis	0.000175	0.00339	CcSEcCtD
Amcinonide—Telangiectasia—Betamethasone—psoriasis	0.000175	0.00339	CcSEcCtD
Amcinonide—Cataract subcapsular—Triamcinolone—psoriasis	0.000174	0.00337	CcSEcCtD
Amcinonide—Atrophy—Cyclosporine—psoriasis	0.000166	0.00322	CcSEcCtD
Amcinonide—Miliaria—Hydrocortisone—psoriasis	0.000164	0.00318	CcSEcCtD
Amcinonide—Secondary infection—Hydrocortisone—psoriasis	0.000164	0.00318	CcSEcCtD
Amcinonide—Acneiform eruption—Dexamethasone—psoriasis	0.000163	0.00316	CcSEcCtD
Amcinonide—Acneiform eruption—Betamethasone—psoriasis	0.000163	0.00316	CcSEcCtD
Amcinonide—Atrophy—Mycophenolate mofetil—psoriasis	0.000162	0.00315	CcSEcCtD
Amcinonide—Folliculitis—Fluocinolone Acetonide—psoriasis	0.000162	0.00313	CcSEcCtD
Amcinonide—Dermatitis contact—Fluocinonide—psoriasis	0.000161	0.00312	CcSEcCtD
Amcinonide—Skin atrophy—Hydrocortisone—psoriasis	0.000159	0.00309	CcSEcCtD
Amcinonide—Cataract subcapsular—Dexamethasone—psoriasis	0.000158	0.00306	CcSEcCtD
Amcinonide—Cataract subcapsular—Betamethasone—psoriasis	0.000158	0.00306	CcSEcCtD
Amcinonide—Skin striae—Prednisolone—psoriasis	0.000155	0.00301	CcSEcCtD
Amcinonide—Secondary infection—Triamcinolone—psoriasis	0.000154	0.00299	CcSEcCtD
Amcinonide—Miliaria—Triamcinolone—psoriasis	0.000154	0.00299	CcSEcCtD
Amcinonide—Telangiectasia—Prednisone—psoriasis	0.000152	0.00295	CcSEcCtD
Amcinonide—Skin striae—Hydrocortisone—psoriasis	0.000151	0.00294	CcSEcCtD
Amcinonide—Atrophy—Prednisolone—psoriasis	0.000151	0.00293	CcSEcCtD
Amcinonide—Skin atrophy—Triamcinolone—psoriasis	0.00015	0.00291	CcSEcCtD
Amcinonide—Atrophy—Hydrocortisone—psoriasis	0.000148	0.00287	CcSEcCtD
Amcinonide—Tenderness—Methoxsalen—psoriasis	0.000147	0.00286	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000144	0.036	CbGpPWpGaD
Amcinonide—Skin striae—Triamcinolone—psoriasis	0.000143	0.00277	CcSEcCtD
Amcinonide—Hypertrichosis—Cyclosporine—psoriasis	0.000142	0.00276	CcSEcCtD
Amcinonide—Acneiform eruption—Prednisone—psoriasis	0.000142	0.00275	CcSEcCtD
Amcinonide—Dermatitis acneiform—Hydrocortisone—psoriasis	0.000141	0.00273	CcSEcCtD
Amcinonide—Secondary infection—Dexamethasone—psoriasis	0.00014	0.00272	CcSEcCtD
Amcinonide—Secondary infection—Betamethasone—psoriasis	0.00014	0.00272	CcSEcCtD
Amcinonide—Miliaria—Betamethasone—psoriasis	0.00014	0.00272	CcSEcCtD
Amcinonide—Miliaria—Dexamethasone—psoriasis	0.00014	0.00272	CcSEcCtD
Amcinonide—Atrophy—Triamcinolone—psoriasis	0.000139	0.0027	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Hydrocortisone—psoriasis	0.000138	0.00267	CcSEcCtD
Amcinonide—Cataract subcapsular—Prednisone—psoriasis	0.000137	0.00266	CcSEcCtD
Amcinonide—Skin atrophy—Dexamethasone—psoriasis	0.000136	0.00264	CcSEcCtD
Amcinonide—Skin atrophy—Betamethasone—psoriasis	0.000136	0.00264	CcSEcCtD
Amcinonide—Dermatitis acneiform—Triamcinolone—psoriasis	0.000133	0.00257	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Triamcinolone—psoriasis	0.00013	0.00252	CcSEcCtD
Amcinonide—Skin striae—Betamethasone—psoriasis	0.000129	0.00251	CcSEcCtD
Amcinonide—Skin striae—Dexamethasone—psoriasis	0.000129	0.00251	CcSEcCtD
Amcinonide—Rash pustular—Fluocinolone Acetonide—psoriasis	0.000127	0.00247	CcSEcCtD
Amcinonide—Telangiectasia—Methotrexate—psoriasis	0.000127	0.00247	CcSEcCtD
Amcinonide—Hypertrichosis—Hydrocortisone—psoriasis	0.000127	0.00246	CcSEcCtD
Amcinonide—Atrophy—Betamethasone—psoriasis	0.000126	0.00245	CcSEcCtD
Amcinonide—Atrophy—Dexamethasone—psoriasis	0.000126	0.00245	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000123	0.0307	CbGpPWpGaD
Amcinonide—Dermatitis acneiform—Betamethasone—psoriasis	0.00012	0.00234	CcSEcCtD
Amcinonide—Dermatitis acneiform—Dexamethasone—psoriasis	0.00012	0.00234	CcSEcCtD
Amcinonide—Hypertrichosis—Triamcinolone—psoriasis	0.000119	0.00231	CcSEcCtD
Amcinonide—Skin atrophy—Prednisone—psoriasis	0.000119	0.0023	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Dexamethasone—psoriasis	0.000118	0.00228	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Betamethasone—psoriasis	0.000118	0.00228	CcSEcCtD
Amcinonide—Leukoderma—Prednisolone—psoriasis	0.000116	0.00225	CcSEcCtD
Amcinonide—Leukoderma—Hydrocortisone—psoriasis	0.000113	0.0022	CcSEcCtD
Amcinonide—Skin striae—Prednisone—psoriasis	0.000113	0.00219	CcSEcCtD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL20—psoriasis	0.000111	0.0279	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000111	0.0277	CbGpPWpGaD
Amcinonide—Atrophy—Prednisone—psoriasis	0.00011	0.00213	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—HCAR2—psoriasis	0.000109	0.0274	CbGpPWpGaD
Amcinonide—Hypertrichosis—Betamethasone—psoriasis	0.000108	0.0021	CcSEcCtD
Amcinonide—Hypertrichosis—Dexamethasone—psoriasis	0.000108	0.0021	CcSEcCtD
Amcinonide—Leukoderma—Triamcinolone—psoriasis	0.000107	0.00207	CcSEcCtD
Amcinonide—Dermatitis acneiform—Prednisone—psoriasis	0.000105	0.00203	CcSEcCtD
Amcinonide—Dermatitis contact—Fluocinolone Acetonide—psoriasis	0.0001	0.00195	CcSEcCtD
Amcinonide—Leukoderma—Dexamethasone—psoriasis	9.67e-05	0.00188	CcSEcCtD
Amcinonide—Leukoderma—Betamethasone—psoriasis	9.67e-05	0.00188	CcSEcCtD
Amcinonide—Hypertrichosis—Prednisone—psoriasis	9.42e-05	0.00183	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—CCL20—psoriasis	9.39e-05	0.0235	CbGpPWpGaD
Amcinonide—Tenderness—Hydroxyurea—psoriasis	9.16e-05	0.00178	CcSEcCtD
Amcinonide—Pain—Calcipotriol—psoriasis	8.8e-05	0.00171	CcSEcCtD
Amcinonide—Folliculitis—Cyclosporine—psoriasis	8.62e-05	0.00167	CcSEcCtD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	8.43e-05	0.0211	CbGpPWpGaD
Amcinonide—Leukoderma—Prednisone—psoriasis	8.42e-05	0.00163	CcSEcCtD
Amcinonide—Rash pustular—Mycophenolic acid—psoriasis	8.39e-05	0.00163	CcSEcCtD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	8.31e-05	0.0208	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—CARM1—psoriasis	8.06e-05	0.0202	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	8.02e-05	0.0201	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL4—psoriasis	7.83e-05	0.0196	CbGpPWpGaD
Amcinonide—Folliculitis—Hydrocortisone—psoriasis	7.66e-05	0.00149	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	7.47e-05	0.0187	CbGpPWpGaD
Amcinonide—Pruritus—Calcipotriol—psoriasis	7.28e-05	0.00141	CcSEcCtD
Amcinonide—Folliculitis—Triamcinolone—psoriasis	7.21e-05	0.0014	CcSEcCtD
Amcinonide—Leukoderma—Methotrexate—psoriasis	7.04e-05	0.00137	CcSEcCtD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	6.99e-05	0.0175	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	6.96e-05	0.0174	CbGpPWpGaD
Amcinonide—Stinging—Cyclosporine—psoriasis	6.68e-05	0.0013	CcSEcCtD
Amcinonide—Rash pustular—Mycophenolate mofetil—psoriasis	6.62e-05	0.00129	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—psoriasis	6.62e-05	0.0166	CbGpPWpGaD
Amcinonide—Folliculitis—Betamethasone—psoriasis	6.54e-05	0.00127	CcSEcCtD
Amcinonide—Folliculitis—Dexamethasone—psoriasis	6.54e-05	0.00127	CcSEcCtD
Amcinonide—Pain—Tazarotene—psoriasis	6.49e-05	0.00126	CcSEcCtD
Amcinonide—Dermatitis—Calcipotriol—psoriasis	6.48e-05	0.00126	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptors—VDR—psoriasis	6.47e-05	0.0162	CbGpPWpGaD
Amcinonide—Infection—Clobetasol propionate—psoriasis	6.39e-05	0.00124	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—ICAM1—psoriasis	6.22e-05	0.0156	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HCAR2—psoriasis	6.19e-05	0.0155	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—NOS2—psoriasis	6.17e-05	0.0155	CbGpPWpGaD
Amcinonide—Stinging—Prednisolone—psoriasis	6.08e-05	0.00118	CcSEcCtD
Amcinonide—Stinging—Hydrocortisone—psoriasis	5.94e-05	0.00115	CcSEcCtD
Amcinonide—Infection—Beclomethasone—psoriasis	5.82e-05	0.00113	CcSEcCtD
Amcinonide—Infection—Fluocinonide—psoriasis	5.77e-05	0.00112	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CCL20—psoriasis	5.69e-05	0.0142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HCAR2—psoriasis	5.62e-05	0.0141	CbGpPWpGaD
Amcinonide—Stinging—Triamcinolone—psoriasis	5.59e-05	0.00109	CcSEcCtD
Amcinonide—Pain—Clobetasol propionate—psoriasis	5.5e-05	0.00107	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	5.44e-05	0.0136	CbGpPWpGaD
Amcinonide—Pruritus—Tazarotene—psoriasis	5.37e-05	0.00104	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	5.12e-05	0.0128	CbGpPWpGaD
Amcinonide—Stinging—Betamethasone—psoriasis	5.08e-05	0.000985	CcSEcCtD
Amcinonide—Stinging—Dexamethasone—psoriasis	5.08e-05	0.000985	CcSEcCtD
Amcinonide—Pain—Beclomethasone—psoriasis	5.01e-05	0.000972	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5e-05	0.0125	CbGpPWpGaD
Amcinonide—Pain—Fluocinonide—psoriasis	4.96e-05	0.000963	CcSEcCtD
Amcinonide—Dermatitis—Tazarotene—psoriasis	4.78e-05	0.000928	CcSEcCtD
Amcinonide—Folliculitis—Methotrexate—psoriasis	4.76e-05	0.000924	CcSEcCtD
Amcinonide—Dermatitis contact—Hydrocortisone—psoriasis	4.76e-05	0.000923	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—IFNG—psoriasis	4.73e-05	0.0119	CbGpPWpGaD
Amcinonide—Pruritus—Clobetasol propionate—psoriasis	4.55e-05	0.000883	CcSEcCtD
Amcinonide—Infection—Methoxsalen—psoriasis	4.55e-05	0.000883	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—psoriasis	4.51e-05	0.0113	CbGpPWpGaD
Amcinonide—Dermatitis contact—Triamcinolone—psoriasis	4.48e-05	0.000869	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—psoriasis	4.4e-05	0.011	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.2e-05	0.0105	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	4.12e-05	0.0103	CbGpPWpGaD
Amcinonide—Pruritus—Fluocinonide—psoriasis	4.11e-05	0.000797	CcSEcCtD
Amcinonide—Dermatitis contact—Betamethasone—psoriasis	4.06e-05	0.000789	CcSEcCtD
Amcinonide—Dermatitis contact—Dexamethasone—psoriasis	4.06e-05	0.000789	CcSEcCtD
Amcinonide—Dermatitis—Clobetasol propionate—psoriasis	4.05e-05	0.000787	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—psoriasis	3.86e-05	0.00968	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL4—psoriasis	3.76e-05	0.00941	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	3.71e-05	0.0093	CbGpPWpGaD
Amcinonide—Dermatitis—Beclomethasone—psoriasis	3.69e-05	0.000716	CcSEcCtD
Amcinonide—Dermatitis—Fluocinonide—psoriasis	3.66e-05	0.00071	CcSEcCtD
Amcinonide—Infection—Acitretin—psoriasis	3.61e-05	0.0007	CcSEcCtD
Amcinonide—Infection—Fluocinolone Acetonide—psoriasis	3.6e-05	0.000698	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	3.57e-05	0.00893	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	3.53e-05	0.00885	CbGpPWpGaD
Amcinonide—Pain—Calcitriol—psoriasis	3.49e-05	0.000678	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	3.44e-05	0.00861	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	3.4e-05	0.00853	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—psoriasis	3.36e-05	0.00841	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HCAR2—psoriasis	3.32e-05	0.00831	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	3.31e-05	0.00829	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	3.25e-05	0.00815	CbGpPWpGaD
Amcinonide—Pruritus—Methoxsalen—psoriasis	3.24e-05	0.000629	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.23e-05	0.0081	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCL20—psoriasis	3.21e-05	0.00805	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	3.13e-05	0.00783	CbGpPWpGaD
Amcinonide—Pain—Acitretin—psoriasis	3.11e-05	0.000603	CcSEcCtD
Amcinonide—Pain—Fluocinolone Acetonide—psoriasis	3.1e-05	0.000601	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—psoriasis	3.06e-05	0.00767	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—psoriasis	3.01e-05	0.00753	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	2.99e-05	0.0075	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.93e-05	0.00735	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL20—psoriasis	2.92e-05	0.00731	CbGpPWpGaD
Amcinonide—Pruritus—Calcitriol—psoriasis	2.89e-05	0.000561	CcSEcCtD
Amcinonide—Dermatitis—Methoxsalen—psoriasis	2.89e-05	0.00056	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—TAGAP—psoriasis	2.88e-05	0.00721	CbGpPWpGaD
Amcinonide—Infection—Hydroxyurea—psoriasis	2.83e-05	0.00055	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.78e-05	0.00697	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—psoriasis	2.7e-05	0.00676	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.68e-05	0.00671	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	2.63e-05	0.00659	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SOCS1—psoriasis	2.62e-05	0.00657	CbGpPWpGaD
Amcinonide—Dermatitis—Calcitriol—psoriasis	2.57e-05	0.000499	CcSEcCtD
Amcinonide—Pruritus—Acitretin—psoriasis	2.57e-05	0.000499	CcSEcCtD
Amcinonide—Pruritus—Fluocinolone Acetonide—psoriasis	2.56e-05	0.000497	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—psoriasis	2.54e-05	0.00635	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—psoriasis	2.47e-05	0.00619	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	2.45e-05	0.00614	CbGpPWpGaD
Amcinonide—Pain—Hydroxyurea—psoriasis	2.44e-05	0.000473	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.43e-05	0.00609	CbGpPWpGaD
Amcinonide—Infection—Mycophenolic acid—psoriasis	2.37e-05	0.00046	CcSEcCtD
Amcinonide—Dermatitis—Acitretin—psoriasis	2.29e-05	0.000444	CcSEcCtD
Amcinonide—Dermatitis—Fluocinolone Acetonide—psoriasis	2.28e-05	0.000443	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	2.27e-05	0.00569	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TARS—psoriasis	2.26e-05	0.00567	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.22e-05	0.00555	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	2.11e-05	0.00529	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.08e-05	0.00522	CbGpPWpGaD
Amcinonide—Pain—Mycophenolic acid—psoriasis	2.04e-05	0.000396	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	2.03e-05	0.0051	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.02e-05	0.00505	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	2e-05	0.00501	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—psoriasis	1.96e-05	0.00492	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—psoriasis	1.94e-05	0.00485	CbGpPWpGaD
Amcinonide—Infection—Cyclosporine—psoriasis	1.92e-05	0.000373	CcSEcCtD
Amcinonide—Infection—Mycophenolate mofetil—psoriasis	1.87e-05	0.000363	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	1.86e-05	0.00466	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.84e-05	0.0046	CbGpPWpGaD
Amcinonide—Dermatitis—Hydroxyurea—psoriasis	1.8e-05	0.000349	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	1.75e-05	0.00438	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	1.73e-05	0.00433	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL20—psoriasis	1.72e-05	0.00432	CbGpPWpGaD
Amcinonide—Infection—Hydrocortisone—psoriasis	1.71e-05	0.000331	CcSEcCtD
Amcinonide—Pruritus—Mycophenolic acid—psoriasis	1.69e-05	0.000328	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—PPARG—psoriasis	1.69e-05	0.00423	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	1.67e-05	0.00417	CbGpPWpGaD
Amcinonide—Pain—Cyclosporine—psoriasis	1.65e-05	0.000321	CcSEcCtD
Amcinonide—Pain—Mycophenolate mofetil—psoriasis	1.61e-05	0.000313	CcSEcCtD
Amcinonide—Infection—Triamcinolone—psoriasis	1.61e-05	0.000312	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—psoriasis	1.54e-05	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.53e-05	0.00383	CbGpPWpGaD
Amcinonide—Dermatitis—Mycophenolic acid—psoriasis	1.5e-05	0.000292	CcSEcCtD
Amcinonide—Pain—Prednisolone—psoriasis	1.5e-05	0.000292	CcSEcCtD
Amcinonide—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	1.48e-05	0.00371	CbGpPWpGaD
Amcinonide—Pain—Hydrocortisone—psoriasis	1.47e-05	0.000285	CcSEcCtD
Amcinonide—Infection—Dexamethasone—psoriasis	1.46e-05	0.000283	CcSEcCtD
Amcinonide—Infection—Betamethasone—psoriasis	1.46e-05	0.000283	CcSEcCtD
Amcinonide—Pain—Triamcinolone—psoriasis	1.38e-05	0.000268	CcSEcCtD
Amcinonide—Pruritus—Cyclosporine—psoriasis	1.37e-05	0.000265	CcSEcCtD
Amcinonide—Pruritus—Mycophenolate mofetil—psoriasis	1.33e-05	0.000259	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—psoriasis	1.3e-05	0.00325	CbGpPWpGaD
Amcinonide—Infection—Prednisone—psoriasis	1.27e-05	0.000246	CcSEcCtD
Amcinonide—Pain—Dexamethasone—psoriasis	1.25e-05	0.000243	CcSEcCtD
Amcinonide—Pain—Betamethasone—psoriasis	1.25e-05	0.000243	CcSEcCtD
Amcinonide—Dermatitis—Cyclosporine—psoriasis	1.22e-05	0.000236	CcSEcCtD
Amcinonide—Pruritus—Hydrocortisone—psoriasis	1.21e-05	0.000236	CcSEcCtD
Amcinonide—Dermatitis—Mycophenolate mofetil—psoriasis	1.19e-05	0.00023	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.19e-05	0.00297	CbGpPWpGaD
Amcinonide—Pruritus—Triamcinolone—psoriasis	1.14e-05	0.000222	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.14e-05	0.00286	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.11e-05	0.00279	CbGpPWpGaD
Amcinonide—Dermatitis—Prednisolone—psoriasis	1.11e-05	0.000215	CcSEcCtD
Amcinonide—Dermatitis—Hydrocortisone—psoriasis	1.08e-05	0.00021	CcSEcCtD
Amcinonide—Infection—Methotrexate—psoriasis	1.06e-05	0.000206	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.05e-05	0.00262	CbGpPWpGaD
Amcinonide—Pruritus—Dexamethasone—psoriasis	1.04e-05	0.000201	CcSEcCtD
Amcinonide—Pruritus—Betamethasone—psoriasis	1.04e-05	0.000201	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—STAT3—psoriasis	1.03e-05	0.00259	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.03e-05	0.00259	CbGpPWpGaD
Amcinonide—Dermatitis—Triamcinolone—psoriasis	1.02e-05	0.000198	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.95e-06	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SOCS1—psoriasis	9.49e-06	0.00238	CbGpPWpGaD
Amcinonide—Dermatitis—Betamethasone—psoriasis	9.24e-06	0.000179	CcSEcCtD
Amcinonide—Dermatitis—Dexamethasone—psoriasis	9.24e-06	0.000179	CcSEcCtD
Amcinonide—Pain—Methotrexate—psoriasis	9.13e-06	0.000177	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—TYK2—psoriasis	9.05e-06	0.00227	CbGpPWpGaD
Amcinonide—Pruritus—Prednisone—psoriasis	9.04e-06	0.000175	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	9.03e-06	0.00226	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—psoriasis	8.96e-06	0.00224	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—VDR—psoriasis	8.84e-06	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—psoriasis	8.68e-06	0.00217	CbGpPWpGaD
Amcinonide—Dermatitis—Prednisone—psoriasis	8.05e-06	0.000156	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—psoriasis	7.88e-06	0.00197	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	7.74e-06	0.00194	CbGpPWpGaD
Amcinonide—Pruritus—Methotrexate—psoriasis	7.55e-06	0.000147	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—IL6—psoriasis	7.23e-06	0.00181	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CARM1—psoriasis	7.12e-06	0.00178	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—psoriasis	7e-06	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—psoriasis	7e-06	0.00175	CbGpPWpGaD
Amcinonide—Dermatitis—Methotrexate—psoriasis	6.73e-06	0.000131	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—NFKBIA—psoriasis	6.53e-06	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	6.25e-06	0.00157	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	6.16e-06	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TYK2—psoriasis	5.35e-06	0.00134	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—psoriasis	4.65e-06	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—psoriasis	4.43e-06	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—psoriasis	4.33e-06	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—VDR—psoriasis	4.25e-06	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NFKB1—psoriasis	4.17e-06	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—psoriasis	3.78e-06	0.000947	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—psoriasis	3.74e-06	0.000938	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—psoriasis	2.97e-06	0.000743	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—psoriasis	2.86e-06	0.000716	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—psoriasis	2.61e-06	0.000655	CbGpPWpGaD
